Stock Markets

Daily coverage of equity markets, sectors, and major indices.

In-depth reporting on U.S. and global stock markets, including index performance, sector rotation, earnings reactions, volatility trends, and notable single-stock moves. Designed to help traders and investors understand what is driving price action across equities.

Articles

20,600 total articles

Insider Moves Monday: Large Purchases at Q32 Bio and Outlook, Major Sales at Medline and Illumina

Insider Moves Monday: Large Purchases at Q32 Bio and Outlook, Major Sales at Medline and Illumina

Insiders and affiliated investment vehicles reported a mix of heavyweight purchases and large-scale disposals on Monday, June 1, 2026. Biotech Q32 Bio and clinical-stage Outlook Therapeutics recorded significant private and registered-direct purchases, while a coordinated block sale at Medline and large fund dispositions of Illumina shares dominate…

Morningstar Pegs SpaceX at $780 Billion, Well Below Company IPO Goal

Morningstar Pegs SpaceX at $780 Billion, Well Below Company IPO Goal

Morningstar's appraisal places SpaceX at $780 billion, substantially lower than the $1.75 trillion valuation the company is targeting for its upcoming IPO. The research house singled out uncertainties around SpaceX's artificial intelligence initiatives, including xAI and X, and noted technological and competitive risks for Starlink and proposed orb…

Morningstar Pegs SpaceX at $780 Billion, Far Below Company's IPO Goal

Morningstar Pegs SpaceX at $780 Billion, Far Below Company's IPO Goal

Morningstar values SpaceX at $780 billion, substantially lower than the company's stated IPO target. The research firm questioned the economics and competitive position of SpaceX's AI initiatives and highlighted technological and external risks for Starlink. Despite near-term upside driven by low float and heavyweight underwriters, Morningstar caut…